Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

By T. Livraghi, F. Meloni, M. Di Stasi, E. Rolle, L. Solbiati, C. Tinelli, S. Rossi. Hepatology, 2007

1,145 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/a125d3c85959ca486f3b9f58f5e342fa92eb783d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

In Hepatology

Citations in the corpus

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “The best outcomes have been reported in Child–Pugh A patients with small single tumors, commonly less than 2 cm in diameter [159,162].”
Hepatocellular carcinoma: a review (2016, background): “The treatment of HCC has been well demonstrated in multiple series with overall 5-year survival rates between 33% and 55%.(136) Ethanol injection requires multiple injections on separate days and rarely induces significant necrosis in tumors >3 cm largely because the injected ethanol rarely reaches ”
Management of hepatocellular carcinoma: An update (2011, neutral): “A cohort study of radiofrequency ablation demonstrated that complete ablation of lesions smaller than 2 cm is possible in more than 90% of cases, with a local recurrence rate of less than 1%.(13) These data should be confirmed by other groups before positioning ablation as the firstline approach for”
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010, background): “5%, respectively [300–305].”
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “The best outcomes have been reported in Child–Pugh A patients with small single tumors, commonly less than 2 cm in diameter [159,162].”
Hepatocellular carcinoma: a global view (2010, result): “Subsequent studies, including two further randomized controlled trials, showed that RFA has similar efficacy to surgical resection in the treatment of early-stage HCCs, and is associated with lower complication rates and costs than resection ( Table 3 )”